Venture Capital

Aardvark Therapeutics is expanding its Phase 3 trial for a novel Prader-Willi Syndrome drug to include children as young as seven, targeting a key unmet need.

With a fresh $28M in funding, Natilus is set to commercialize its hyper-efficient blended-wing aircraft, threatening the Boeing-Airbus duopoly.

Ahead of its first Climate Week, Mumbai's food innovators and activists gather to debate a sustainable future, proving the fight for the planet begins on our plates.

The drive-thru coffee giant is moving into your kitchen, taking on Starbucks and Nestlé with its new retail line. But can its 'Dutch Luv' succeed on shelves?

Amid major restructuring and a strategic asset sale, Standard BioTools' upcoming annual results will reveal its progress toward profitability in a tough market.

A new AI-native law firm uses tech to find dangerous products decades early, promising faster justice. But is it a revolution or a regulatory risk?

Enanta Pharmaceuticals unveils promising data for EDP-978, an oral drug targeting the root cause of conditions like chronic hives, asthma, and eczema.

A key partnership between Silicon Catalyst and Chiplet Summit 2026 aims to accelerate the next wave of semiconductor innovators in a booming market.

The advisory giant's acquisition of a Boston-based specialist signals a strategic push into the high-stakes, high-growth world of life sciences and biotech.

The firm's $0.47 Q4 dividend is backed by record income and improving credit quality, offering a compelling case for income and global investors.

A groundbreaking partnership in Italy is creating an AI-powered biobank to transform cancer diagnosis, promising faster, more accurate results for patients.

The 16th Lumiere Awards honor films like 'Sinners' and tech giants like Google, signaling a new era where AI is the co-star in cinematic innovation.

As schools adopt Copilot+ PCs and iOS, Saasyan's new update aims to provide seamless online safety monitoring across a diverse digital classroom.

Belgian biotech Agomab Therapeutics secures $200 million in its Nasdaq debut, fueling its mission to develop therapies for debilitating fibrotic conditions.

As the AI coding market heats up, Cursor's strategic hire of Brian McCarthy signals a major push for enterprise dominance against rivals like GitHub Copilot.

AMD hires Ariel Kelman, a marketing veteran from AWS and Salesforce, to sharpen its brand and accelerate its push into the lucrative AI data center market.

A new company aims to solve why patients stop neurological treatments, focusing on the critical, unsupported time between doctor appointments.

New AI assistants are automating tedious workforce tasks for front-line leaders, promising to free up time and combat rising labor costs and staff shortages.

As the hydrogen economy booms, ANSI is creating the essential safety and technical rulebook needed to unlock its full, clean energy potential.

The pantry brand launches 10 new Regenerative Organic Certified products, expanding its global reach and betting big on a truly sustainable food future.